No abstract available
Plain language summary
This study evaluates whether organizations that offer Medicare Part D plans (referred to as Part D sponsors) overpay pharmacies for generic drugs.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cost Sharing
-
Drug Costs
-
Drugs, Generic* / economics
-
Insurance, Health, Reimbursement* / economics
-
Medicare Part D* / economics
-
Pharmacies* / economics
-
Prescription Drugs* / economics
-
United States
Substances
-
Drugs, Generic
-
Prescription Drugs